Observe Medical – Nya Karolinska Sjukhuset in Sweden resumes the implementation of Sippi® in clinical use at Cardiothoracic ICU unit

Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19   

As a result of the recent improvements of the Covid-19 situation at the hospital, the Department of Cardiothoracic Anaesthesiology and Intensive Care at Nya Karolinska Sjukhuset, has decided to resume the implementation of Sippi® in clinical use. The implementation will start in February, and will be done in a stepwise manner, with a limited number of Sippi® units utilized in a first phase, followed by planned full implementation at the Department later this year. The implementation was originally initiated during early 2020 but paused due to the constrained situation in the hospital, caused by Covid-19.

 Sippi® has previously been investigated in a clinical study at the Cardiothoracic ICU Department at Nya Karolinska Sjukhuset. The study forms part of the thesis “Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation due to proteinuria, hemoglobinuria and bacterial growth” by Dr. Martin Slettengren who recently dissertated at the Dept. of Molecular Medicine and Surgery, Karolinska Institute in Stockholm on January 14, 2021 (see press release from Observe Medical on January 15, 2021).

 “We are pleased that Nya Karolinska Sjukhuset – a leading university hospital in Europe, has decided to resume the implementation of Sippi at the Cardiothoracic ICU Department. This may onwards serve as a reference for other departments at the same hospital as well as at other hospitals” says Björn Larsson, CEO Observe Medical.

Observe Medical is currently launching Sippi® automated digital urine meter with the short-term focus of accelerating the clinical use of Sippi® in the Nordics and selected markets in Europe.

For further information, please contact:

Observe Medical: Björn Larsson, CEO, +46 76 620 17 25, bjorn.larsson@observemedical.com


About Observe Medical

https://observemedical.com/ Observe Medical develops, markets, and sells innovative hospital products that contribute to increased patient safety and a more efficient care system. The company’s ambition is to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in the areas of Urine measurement, Anesthesiology/ICUs, and wound care, in combination with targeted M&A. The company’s headquarter is in Oslo, Norway and its operations are based out of Gothenburg, Sweden. Observe Medical has a direct sales organization in the Nordics and a distributor network internationally. Observe Medical's product, Sippi®, is the only automated digital urine meter with the possibility for wireless data transfer to hospital patient data management systems and hinders bacterial migration that can lead to urinary infections (Sippcoat®). Sippi® is CE marked and currently being launched with a focus on selected markets and hospitals in the Nordics and in Europe.